Tenaya Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Tenaya Therapeutics is a clinical-stage biotechnology company focused on discovering, designing, developing, and delivering therapies that address the underlying drivers of heart disease. It seeks to alter the treatment paradigm for heart disease by pursuing disease-modifying therapies for defined sub-populations, including both rare and highly prevalent forms. Founded in 2016 by leading cardiovascular scientists from the Gladstone Institutes and the University of Texas Southwestern Medical Center, the company is based in South San Francisco in the Bay Area. Tenaya is advancing a pipeline built on its internal capabilities to target defined sub-populations of patients with heart disease. In March 2026, the company announced a research collaboration with Alnylam Pharmaceuticals to identify and validate novel genetic targets for cardiovascular disease therapeutics.